The efficacy of Curcumin in treatment of Non-Alcoholic Fatty Liver Disease

Phase 2

• Conditions: Fatty Liver.; Fatty (change of) liver, not elsewhere classified

• Registration Number: IRCT2015122525641N2
• Lead Sponsor: Vice chancellor for research of Baqiyatallah University of Medical Science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

patient has Fatty Liver; The history of allergic reaction to the drug combination is not relevant; Over 18 years old; The patient has informed consent to participate in the study;
Exclusion criteria:
The patient who stops the medication more than 1 week; The patient with the history of biliary disease; The patient with Fatty Liver, who also has Hyperlipidemia and receives statins; Patient with Fatty Liver, who also has another liver disease; Pregnancy and lactation; The patient who expresses uncontrolled adverse effects by this drug; alcohol consumption and any addictive drugs.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The accumulation of liver fat. Timepoint: Before the intervention, 8 weeks later at the end of the intervention. Method of measurement: Color Doppler Ultrasonography.